PEG-rHuMGDF ameliorates thrombocytopenia in carboplatin-treated rats without inducing myelofibrosis

International Journal of Hematology

Volumn 70, Issue 2, 1999, Pages 91-96

  Ide, Youichi ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

Myelofibrosis; PEG rHuMGDF; Rat; Thrombocytopenia; Transforming growth factor 1

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; MACROGOL DERIVATIVE; POLYETHYLENE GLYCOL RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; POLYETHYLENE GLYCOL-RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT PROTEIN; THROMBOPOIETIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; HUMAN; MALE; MYELOFIBROSIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MYELOFIBROSIS; POLYETHYLENE GLYCOLS; RATS; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 0033174423     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Bartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-24.